Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
about
50 Years of progress in the systemic therapy of non-small cell lung cancerCisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study.A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancerContinuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacyA pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.Management of lung cancerPalliative care--an essential component of cancer controlLocal complications of non-small-cell lung cancer.Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.Lung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.Symptom control.Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic.Chemotherapy for cancer patients who present late.Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors.How should cancer presenting as a malignant pleural effusion be managed?Anticancer therapies in specialized palliative care--a multicenter surveyState of the art in therapy for non-small cell lung cancer.Lung cancer: Biology and treatment options.Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesotheliomaDo patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?NCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting.Targeted therapy in non-small-cell lung cancer--is it becoming a reality?Metaanalysis of the correlation between radiographic tumor response and patient-reported outcomes.Palliative chemotherapy.Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma.New Agents in the Management of Non-Small Cell Lung Cancer.Chemotherapy for advanced (stage IIIB and stage IV) non-small cell lung cancer: the Hong Kong perspective.Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial.Palliative Care for Children with Advanced Cancer
P2860
Q27014978-E1DDDDCA-8DE0-48E4-8B4E-B71FFFC4371DQ33371199-34012ABF-0DA8-45C1-ACBB-A682954680A8Q33489857-63F96740-A3B9-4091-88F3-CB8558C662DAQ33501194-2241DAA6-DD99-4170-9BB3-8690A9AB0C9BQ33503060-D5EAE0D9-C01E-48A3-8520-481C5A657294Q33583714-97492962-C547-4A2E-A951-330C29D454CDQ34028975-458C5550-86D8-44F6-9A34-EF23DDDDEF08Q34677886-D4F90140-618B-4D09-B78F-F81187945F08Q34982142-DF12CED5-EAB4-467E-B9C0-4DBF7771766BQ35096015-D7A0CB59-822D-4ACC-BF75-9CBE18C67E30Q35553856-B6E49B7F-1E20-4BA6-AC67-214B5E52EE53Q35584482-93DCF8F9-5992-4D62-AA69-665678D1F620Q35802013-3D2226A8-C7C8-432C-B7F5-455BE738A5C6Q36114807-82D7C515-68D5-4FEE-BDD4-27CE72027202Q36136037-BFB52F91-D7AA-4FCA-9FA1-1D8F7D824BDCQ36199142-5E1161A6-F72D-45B0-9642-21C6D596D009Q36271949-3D85DC04-4084-4F0E-BBD8-5479523853C2Q36328370-EC50BF17-B91A-49ED-B7D6-2C5884694D26Q36616994-D75AB47B-823B-4403-A63A-1E736AB080CDQ36619174-A95E4A85-776C-408B-B864-BCE47109EC0AQ36642252-67FD8518-7ECF-4467-9959-F7B6352A4ED8Q36694116-0CC58C00-4910-40E3-8DB8-290FE0996CD7Q37763136-B03805A2-B891-4E91-874B-658837EA95F4Q37765472-30190279-CBCE-4DCA-88B8-F38C9428091FQ40365317-02C6FD8C-6B20-4024-A216-EA8D7DDD7219Q41739152-5A4D60B0-95D4-45C7-9D34-53ABB23C9A93Q44141804-C07ACEC5-7D1D-44AE-86A2-4B3D970500C8Q47620441-C5215700-01D1-4304-B0ED-FA8F2ADB9AE4Q48712834-609465D0-2D9A-4F6E-98EB-39644619B76AQ53555247-9FC160EC-0F30-40C6-B135-31F6E38336B1Q57821785-3E9C23D3-E260-4297-B083-87DB8D2C3294
P2860
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Symptom relief with MVP (mitom ...... ced non-small-cell lung cancer
@ast
Symptom relief with MVP (mitom ...... ced non-small-cell lung cancer
@en
type
label
Symptom relief with MVP (mitom ...... ced non-small-cell lung cancer
@ast
Symptom relief with MVP (mitom ...... ced non-small-cell lung cancer
@en
prefLabel
Symptom relief with MVP (mitom ...... ced non-small-cell lung cancer
@ast
Symptom relief with MVP (mitom ...... ced non-small-cell lung cancer
@en
P2093
P2860
P356
P1476
Symptom relief with MVP (mitom ...... ced non-small-cell lung cancer
@en
P2093
Nicolson MC
P2860
P2888
P304
P356
10.1038/BJC.1995.74
P407
P577
1995-02-01T00:00:00Z
P5875
P6179
1039124507